Ablation Catheters Market in the US 2015-2019
About Ablation Catheter
Cardiac arrhythmia is one of the leading causes of premature death and is characterized by the abrupt loss of heart function. Cardiac dysfunction results in the inhibition of blood flow to the brain and other vital organs. Arrhythmia is a condition resulting in abnormal heartbeat, which occurs due to changes in electrical impulses. The electrical impulses can either be too fast or too slow, resulting in sudden cardiac arrest. According to a 2013 report by the AHA, more than 450,000 people die annually in the US because of sudden cardiac arrest.
Catheter ablation is an endovascular procedure that is helpful in the treatment of irregular heartbeat. Ablation catheters use an energy source such as radiofrequency, which produces radio waves that generate heat. Ablation catheters reduce the risk of ventricular fibrillation and sudden cardiac arrest.
Technavio's analysts forecast the ablation catheters market in the US is expected to grow at a CAGR of 12.23% over the period 2014-2019.
Covered in this Report
The report includes the present scenario and the growth prospects of the ablation catheters market in the US for the period 2015-2019. The market can be segmented into two types: Single point ablation catheter and multi-electrode ablation catheter.
Technavio's report, Ablation Catheters Market in the US 2015-2019, has been prepared based on in-depth market analysis with inputs from industry experts. The report includes a discussion of the key vendors.
Technavio Announces the Publication of its Research Report – Ablation Catheters Market in the US 2015-2019
Technavio recognizes the following companies as the key players in the Ablation Catheters Market in the US: Biosense Webster (A J&J company), Boston Scientific, Medtronic and St. Jude Medical
Other Prominent Vendors in the market are: Advanced Cardiac Therapeutics, Angiodynamics, APT MEDICAL, Atricure, Biotronik, CardioFocus, Covidien, DVx, Edwards Lifesciences, Estech, Hansen Medical, Imricor Medical Systems, Japan Lifeline, LEPU MEDICAL, Melys AFSM, MicroPort, Osypka, PLC Medical Systems, Spectranetics and Stereotaxis
Commenting on the report, an analyst from Technavio’s team said: “Vendors are focusing on developing innovative ablation catheter devices through application of advanced technology. They also aim to reduce the manufacturing costs to provide efficient and useful tools to deliver tailored treatments to patients. For instance, St. Jude Medical received FDA approval for Flexibility Ablation Catheters, an irrigated ablation catheter with a flexible tip, in the US in January 2015.”
According to the report, catheter ablation is a Minimally Invasive (MI) procedure that helps remove faulty electrical pathways in the heart. Atrial Fibrillation (AF) is one of the leading causes of stroke in the US and affects over 5 million people. About 240,000 catheter ablation procedures were performed in the US in 2014. Therefore, rise in incidence of AF has led to rise in demand for ablation catheter procedures.
Further, the report states that shortage of skilled professionals is a major challenge restricting market growth.
Biosense Webster (A J&J company), Boston Scientific, Medtronic, St. Jude Medical, Advanced Cardiac Therapeutics, Angiodynamics, APT MEDICAL, Atricure, Biotronik, CardioFocus, Covidien, DVx , Edwards Lifesciences, Estech, Hansen Medical, Imricor Medical Systems, Japan Lifeline, LEPU MEDICAL, Melys AFSM, MicroPort, Osypka, PLC Medical Systems, Spectranetics, Stereotaxis
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook